Active idiotypic vaccination versus control immunotherapy for follicular lymphoma Academic Article uri icon

Overview

MeSH Major

  • Cancer Vaccines
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Hemocyanin
  • Immunoglobulin Idiotypes
  • Lymphoma, Follicular

abstract

  • This trial failed to demonstrate clinical benefit of specific immunotherapy. The subset of vaccinated patients mounting specific anti-Id responses had superior outcomes. Whether this reflects a therapeutic benefit or is a marker for more favorable underlying prognosis requires further study.

publication date

  • June 10, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4039868

Digital Object Identifier (DOI)

  • 10.1200/JCO.2012.43.9273

PubMed ID

  • 24799467

Additional Document Info

start page

  • 1797

end page

  • 803

volume

  • 32

number

  • 17